Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Proposes Unilateral Solution To Northern Ireland Medicines Supply Problems

UK Plans Special Contingency Measure

Executive Summary

The latest proposals for solving regulatory and trade issues caused by Brexit and the Northern Ireland Protocol have been welcomed by EU and UK pharmaceutical industry bodies.

You may also be interested in...



EU’s Northern Ireland Drug Supply Solution Imminent

The European Commission’s legislative proposal will close the gaps in medicines regulation caused by Brexit and the Northern Ireland Protocol.

EU’s Northern Ireland Drug Supply Solution Imminent

The European Commission’s legislative proposal will close the gaps in medicines regulation caused by Brexit and the Northern Ireland Protocol.

UK Regulator ‘Optimistic’ About EU Proposals For Northern Ireland Drug Supply

Among the many problems thrown up by Brexit is how to deal with situations where an innovative product that falls within the scope of the EU centralized procedure is filed in Great Britain but not in the EU, potentially denying access to the medicine in Northern Ireland. A recent webinar saw officials from the UK regulator explain the new rules on medicines supply between GB and NI.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS145429

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel